ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 82 filers reported holding ENZO BIOCHEM INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $8,911,000 | +58.2% | 1,284,014 | +16.0% | 0.00% | +100.0% |
| Q3 2016 | $5,632,000 | -8.5% | 1,106,528 | +7.3% | 0.00% | 0.0% |
| Q2 2016 | $6,154,000 | +1430.8% | 1,030,773 | +1067.3% | 0.00% | – |
| Q1 2016 | $402,000 | -5.9% | 88,301 | -6.9% | 0.00% | – |
| Q4 2015 | $427,000 | +48.8% | 94,875 | +4.9% | 0.00% | – |
| Q3 2015 | $287,000 | -9.7% | 90,428 | -13.8% | 0.00% | – |
| Q2 2015 | $318,000 | -89.3% | 104,881 | -89.6% | 0.00% | -100.0% |
| Q1 2015 | $2,969,000 | -32.2% | 1,006,579 | +2.0% | 0.00% | 0.0% |
| Q4 2014 | $4,382,000 | +3.6% | 986,831 | +20.1% | 0.00% | 0.0% |
| Q3 2014 | $4,231,000 | -5.9% | 821,593 | -4.0% | 0.00% | 0.0% |
| Q2 2014 | $4,494,000 | +962.4% | 856,016 | +741.4% | 0.00% | – |
| Q1 2014 | $423,000 | +42.9% | 101,734 | +0.4% | 0.00% | – |
| Q4 2013 | $296,000 | +20.8% | 101,281 | +4.4% | 0.00% | – |
| Q3 2013 | $245,000 | +31.7% | 97,051 | +8.4% | 0.00% | – |
| Q2 2013 | $186,000 | – | 89,491 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roumell Asset Management, LLC | 2,436,771 | $7,822,000 | 10.43% |
| VIEX Capital Advisors, LLC | 1,736,087 | $5,573,000 | 8.96% |
| HARBERT FUND ADVISORS, INC. | 5,175,913 | $16,615,000 | 4.19% |
| AMH Equity Ltd | 596,742 | $1,916,000 | 2.66% |
| Potomac Capital Management, Inc. | 208,000 | $668,000 | 0.59% |
| Agate Pass Investment Management, LLC | 24,292 | $78,000 | 0.05% |
| RBF Capital, LLC | 250,359 | $804,000 | 0.05% |
| KEMPNER CAPITAL MANAGEMENT INC. | 25,475 | $82,000 | 0.05% |
| Corsair Capital Management | 58,657 | $188,000 | 0.04% |
| BOOTHBAY FUND MANAGEMENT, LLC | 319,500 | $1,026,000 | 0.02% |